Related Experiment Video
Updated: Jun 6, 2026

06:30
Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform
Published on: May 17, 2021
A FRAME response to the Draft Report on Alternative (Non-animal) Methods for Cosmetics Testing: Current Status and
Michael Balls1, Richard Clothier
1Fund for the Replacement of Animals in Medical Experiments (FRAME), Nottingham, UK. michael.balls@btopenworld.com
Alternatives to Laboratory Animals : ATLA
|November 26, 2010
Summary
The European Commission
Area of Science:
- Toxicology
- Regulatory Science
- Cosmetic Science
Background:
- The European Commission is developing a report on alternative methods for cosmetic testing.
- A ban on animal testing for cosmetics is scheduled, with some exceptions until 2013.
- Existing regulations for cosmetics, REACH, and other chemical safety directives create complexity.
Purpose of the Study:
- To provide feedback on the draft chapters of the European Commission's report on alternative cosmetic testing methods.
- To highlight deficiencies in the draft report concerning cosmetic ingredient safety assessment.
- To address the uncertainty in applying cosmetic safety regulations alongside REACH.
Main Methods:
- Analysis of the European Commission's draft report chapters.
- Formulation of comments and feedback on behalf of FRAME (Fund for the Replacement of Animals in Medical Experiments).
- Review of existing regulatory frameworks, including the Cosmetics Directive and REACH.
Main Results:
- The draft chapters lack sufficient focus on the specific properties of cosmetic ingredients.
- Insufficient consideration is given to local effects, metabolism, and potential systemic absorption and accumulation of ingredients.
- The draft report does not provide a credible basis for the Commission's upcoming report on cosmetic ingredient safety.
Conclusions:
- The current draft chapters are inadequate for assessing cosmetic ingredient safety due to a lack of specific focus.
- Further refinement is needed to address ingredient-specific absorption, metabolism, and toxicological thresholds.
- Regulatory clarity is required for the consistent application of the Cosmetics Directive, REACH, and other chemical safety regulations.
More Related Videos
Related Concept Videos
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

